Golden has been acquired by ComplyAdvantage.Read about it here ⟶

NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics is a clinical-stage biopharmaceutical company, focusing on the discovery and development of targeted innovative therapeutics for neurodegenerative diseases.

Overview Structured Data Issues Contributors Activity

neurosense-tx.com

neurosenseconsulting.com

Is a

Company

Organization

Company attributes

Industry

Amyotrophic lateral sclerosis

Location

Cambridge, Massachusetts

CEO

Pitchbook URL

pitchbook.com/profiles...289950-04

Legal Name

NeuroSense Therapeutics Ltd.0

Number of Employees (Ranges)

11 – 50

Email Address

info@neurosense-tx.com0

Phone Number

+9725875311530

+16178612946

Full Address

Ha-Menofim 11, Herzliya, Israel0

One Broadway, Broadway, Cambridge, MA, USA0

CIK Number

1,875,0910

Place of Incorporation

Israel

Founded Date

January 1, 2013

Stock Symbol

NRSN0

Exchange

Board of Directors

CFO

Country

Other attributes

Blog

neurosense-tx.com/blog/

Company Operating Status

Active

Contact Page URL

neurosense-tx.com/contact-us/

SIC Code

2,8340

Ticker Symbol

NRSN0

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like NeuroSense Therapeutics Ltd.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.